FDA Inspection 1039672 — Serena Ann Klugh, M.D.
The FDA completed an inspection of Serena Ann Klugh, M.D. on Jan 19, 2018 in Las Vegas, NV. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jan 19, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Las Vegas, NV (United States)
Additional Details
Clinical Investigator (CI)